University of Sydney researchers have been awarded more than $10 million in funding for five new clinical trials in health and medical research projects.
The Minister of Health and Aged Care, the Hon. Greg Hunt, recently announced the successful National Health and Medical Research Council (NHMRC) grants. Sydney researchers have been awarded more than $10 million in funding for five new clinical trials in health and medical research projects.
Pro-Vice-Chancellor, Research, Professor Laurent Rivory says the grants are further recognition of the high-quality research being done at the University.
"This is an impressive NHMRC result for our health and medical researcher community, and recognition of the positive impact of our research on the broader community", said Professor Laurent Rivory (Pro-Vice-Chancellor, Research).
Highlights of grants awarded to Sydney researchers in this round include:
- Professor Trevor Leong - awarded $621,644 for AGITG TOP GEAR: A randomised phase II/III trial of preoperative chemoradiotherapy versus preoperative chemotherapy for resectable gastric cancer.
- Dr Christina Abdel Shaheed - awarded $2.3 million for IMPLORE - Implementing an opioid stewardship intervention to reduce opioid use.
- Associate Professor Camille Raynes-Greenow - awarded $2.9 million for reducing household air pollution exposure to improve early child health and development; extending the intervention and follow-up of "Poriborton: the CHANge trial".
- Associate Professor Kirsten Morle - awarded $1.2 million for a randomised controlled trial of N’acetylcysteine for the treatment of alcohol use disorder.
- Professor Ian Hickie - awarded $3.4 million for a large-scale clinical effectiveness (health services) trial to determine whether personalised health care packages, combined with digitally-supported measurement-based care, improve functional outcomes in young people with mood disorders.
A full list of grant recipients and further details are available on the NHMRC website.
University of Sydney pharmacy researchers have received over $6.5 million in federal government funding to help osteoporosis sufferers and people at risk of chronic kidney disease, and to develop a system to help pharmacists and GPs work better together.